Issue date: May 2010 ; Review date: September 2011.
"This guidance replaces 'NICE technology appraisal guidance 40' issued in April 2002"--Page 4.
Infliximab (review) and adalimumab for the treatment of Crohn's disease : Includes a review of NICE technology appraisal guidance 40 by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence in 2010. Publication and catalogue information, links to buy online and reader comments.